• Title

    Reimbursement of Altuviiio recommended, but…

    | 03/07/2025

    MONTRÉAL, July 3, 2025 – In June, both Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) released their final recommendations on...

    Kathy Mulder appointed to the Order of Canada

    | 01/07/2025

    Montréal, July 1, 2025 – On this very special 2025 Canada Day, the CHS could not be prouder as, yesterday, Kathy Mulder, a long-acting volunteer and health care provider...

    NEW BOOKLET! All About Novel Therapies

    | 30/06/2025

    The CHS is very proud to present its latest publication, the first component of its brand-new Novel Therapies Education Program. CLICK HERE to access the online booklet.

    Health Canada approves Altuviiio

    | 31/03/2025

    MONTRÉAL, March 31, 2025 – Health Canada has granted marketing approval to Altuviiio (efanesoctocog alfa) for the treatment of hemophilia A in children, adolescents and adults. It was approved...

Canadian Hemophilia Society
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.